Brief: Cosmo Pharmaceuticals Announces Regulatory Approval Of Gi Genius In Israel

Cosmo NV

23/06/2020 06:04

June 23 (Reuters) - COSMO PHARMACEUTICALS NV  COPN.S :
    * ANNOUNCES REGULATORY APPROVAL OF GI GENIUS™ IN ISRAEL
    * TRIAL REQUIRED FOR GI GENIUS™ REGISTRATION IN U.S. WHICH
COMMENCED EARLIER THIS YEAR AND WHICH WAS SUBSTANTIALLY HALTED
DUE TO COVID-19 IS NOW RESUMING
    * TRIAL IS EXPECTED TO LAST APPROXIMATELY 4-6 MONTHS

Source text for Eikon:  ID:nTENtizv0a 
Further company coverage:  COPN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))